UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Botulinumtoxin in der ästhetischen Medizin

2nd Aufl 2020 edition, 2020

Volltextzugriff (PDF)

Teil 2: Glabella-Falten

Ästhetische Dermatologie & Kosmetologie, 2021-02, Vol.13 (1), p.22-27

Hilton, Said

2021

Volltextzugriff (PDF)

Botulinumtoxin in der ästhetischen Dermatologie: Lehrbuch Für Die Praxis

2, 2020

Volltextzugriff (PDF)

Botulinumtoxin A beim Mann

Ästhetische Dermatologie & Kosmetologie, 2018-12, Vol.10 (6), p.18-21

2018

Volltextzugriff (PDF)

Teil 4: Botulinumtoxin A beim Mann

Ästhetische Dermatologie & Kosmetologie, 2021-06, Vol.13 (3), p.30-33

2021

Volltextzugriff (PDF)

Teil 3: Musculus masseter

Ästhetische Dermatologie & Kosmetologie, 2021-04, Vol.13 (2), p.20-23

2021

Volltextzugriff (PDF)

Current Concepts in Aesthetic Laser Medicine: The 694-Nm Q-Switched Ruby-Laser

European medical journal. Dermatology, 2014-11, Vol.2 (1), p.56-60

2014

Volltextzugriff (PDF)

Treatment of melasma in Caucasian patients using a novel 694-nm Q-switched ruby fractional laser

European journal of medical research, 2013-11, Vol.18 (1), p.43-43, Article 43

2013

Volltextzugriff (PDF)

Hyaluronidase: from clinical applications to molecular and cellular mechanisms

European journal of medical research, 2016-02, Vol.21 (5), p.5-5, Article 5

2016

Volltextzugriff (PDF)

Clinical outcomes after lip injection procedures—Comparison of two hyaluronic acid gel fillers with different product properties

Journal of cosmetic dermatology, 2023-01, Vol.22 (1), p.119-127

2023

Volltextzugriff (PDF)

Patient and Investigator Treatment Experience With Ready-to-Use AbobotulinumtoxinA Solution Versus Powder BotulinumtoxinA for Treatment of Glabellar Lines

Toxicon (Oxford), 2024-01, Vol.237, p.107474, Article 107474

2024

Volltextzugriff (PDF)

Long-term Efficacy and Safety of Liquid AbobotulinumtoxinA Formulation for Moderate-to-Severe Glabellar Lines: A Phase III, Double-Blind, Randomized, Placebo-Controlled and Open-Label Study

Aesthetic surgery journal, 2022-02, Vol.42 (3), p.301-313

2022

Volltextzugriff (PDF)

Long-term efficacy and safety of abobotulinumtoxinA solution for the treatment of moderate-to-severe glabellar lines: A Phase III, double-blind, placebo-controlled and open-label repeat injection study

Toxicon (Oxford), 2021-01, Vol.190, p.S40-S40

2021

Volltextzugriff (PDF)

Treatment of facial lipatrophy

MMW Fortschritte der Medizin, 2009-04, Vol.151 (18), p.40

Hilton, Said

2009

Volltextzugriff (PDF)

Randomized, Evaluator-Blinded Study Comparing Safety and Effect of Two Hyaluronic Acid Gels for Lips Enhancement

Dermatologic surgery, 2018-02, Vol.44 (2), p.261-269

2018

Volltextzugriff (PDF)

Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment

Dermatologic surgery, 2022-11, Vol.48 (11), p.1198

2022

Volltextzugriff (PDF)

15491 Systematic literature review examining efficacy of abobotulinumtoxinA for esthetic indications

Journal of the American Academy of Dermatology, 2020-12, Vol.83 (6), p.AB154-AB154

2020

Volltextzugriff (PDF)

Ready‐to‐use abobotulinumtoxinA solution versus powder botulinumtoxinA for treatment of glabellar lines: Investigators' and subjects' experience in a Phase IV study

Journal of cosmetic dermatology, 2024-09, Vol.23 (9), p.2857-2866

2024

Volltextzugriff (PDF)

Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial

Aesthetic surgery journal, 2020-08, Vol.40 (9), p.1000-1008

2020

Volltextzugriff (PDF)

Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines

Aesthetic surgery journal, 2020-01, Vol.40 (1), p.93-104

2020

Volltextzugriff (PDF)

A prospective, open-label, multicenter, observational, postmarket study of the use of a 15 mg/mL hyaluronic acid dermal filler in the lips

Journal of cosmetic dermatology, 2014-06, Vol.13 (2), p.125-134

2014

Volltextzugriff (PDF)

Fillerbehandlung bei Gesichtsfalten

Ästhetische Dermatologie & Kosmetologie, 2015-06, Vol.7 (3), p.23-30

2015

Volltextzugriff (PDF)

PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data

Aesthetic surgery journal, 2022-12, Vol.42 (12), p.1460-1469

2022

Volltextzugriff (PDF)

Hyaluronidase injection for the treatment of eyelid edema: a retrospective analysis of 20 patients

European journal of medical research, 2014-05, Vol.19 (1), p.30-30, Article 30

2014

Volltextzugriff (PDF)

Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines

Aesthetic surgery journal, 2021-10, Vol.41 (11), p.1338-1338

2021

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Deutsch
(31)
Englisch
(30)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Humans
(18)
Adult
(11)
Surgery
(10)
Dermatology
(9)
Treatment Outcome
(9)
Female
(8)
Male
(8)
Middle Aged
(8)
Skin Aging
(8)
Aged
(6)
Double-Blind Method
(6)
Forehead
(5)
Botulinum Toxins, Type A - Adverse Effects
(4)
Hyaluronic Acid
(4)
Hyaluronic Acid - Adverse Effects
(4)
Neuromuscular Agents - Adverse Effects
(4)
Patient Satisfaction
(4)
Young Adult
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Botulinumtoxin in der ästhetischen Medizin

Teil 2: Glabella-Falten

Botulinumtoxin in der ästhetischen Dermatologie: Lehrbuch Für Die Praxis

Botulinumtoxin A beim Mann

Teil 4: Botulinumtoxin A beim Mann

Teil 3: Musculus masseter

Current Concepts in Aesthetic Laser Medicine: The 694-Nm Q-Switched Ruby-Laser

Treatment of melasma in Caucasian patients using a novel 694-nm Q-switched ruby fractional laser

Hyaluronidase: from clinical applications to molecular and cellular mechanisms

Clinical outcomes after lip injection procedures—Comparison of two hyaluronic acid gel fillers with different product properties

Patient and Investigator Treatment Experience With Ready-to-Use AbobotulinumtoxinA Solution Versus Powder BotulinumtoxinA for Treatment of Glabellar Lines

Long-term Efficacy and Safety of Liquid AbobotulinumtoxinA Formulation for Moderate-to-Severe Glabellar Lines: A Phase III, Double-Blind, Randomized, Placebo-Controlled and Open-Label Study

Long-term efficacy and safety of abobotulinumtoxinA solution for the treatment of moderate-to-severe glabellar lines: A Phase III, double-blind, placebo-controlled and open-label repeat injection study

Treatment of facial lipatrophy

Randomized, Evaluator-Blinded Study Comparing Safety and Effect of Two Hyaluronic Acid Gels for Lips Enhancement

Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment

15491 Systematic literature review examining efficacy of abobotulinumtoxinA for esthetic indications

Ready‐to‐use abobotulinumtoxinA solution versus powder botulinumtoxinA for treatment of glabellar lines: Investigators' and subjects' experience in a Phase IV study

Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial

Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines

A prospective, open-label, multicenter, observational, postmarket study of the use of a 15 mg/mL hyaluronic acid dermal filler in the lips

Fillerbehandlung bei Gesichtsfalten

PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data

Hyaluronidase injection for the treatment of eyelid edema: a retrospective analysis of 20 patients

Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines

Suchergebnisse filtern